Preventice Solutions, Inc.

Activity by year

202120222023202420252026

AcquisitionContract

Feb 2, 2022CONTRACT$45.0M
Bittium Biosignals extends supply agreement with Preventice Solutions for ECG monitoring devices
Bittium Biosignals, a subsidiary of Bittium Corporation, signed an extension agreement with Preventice Solutions (a Boston Scientific subsidiary) to supply BodyGuardian MINI ECG monitoring devices. The agreement is valued at approximately USD 40-45 million, with revenues accruing from 2022 to 2025.
Bittium Bittium Biosignals Ltd Boston Scientific partner Preventice Solutions, Inc. customer #Medical Devices news.cision.com
Jan 21, 2021ACQUISITIONUnited States$925.0M
Boston Scientific to acquire Preventice Solutions for up to $1.225 billion
Boston Scientific has entered into a definitive agreement to acquire Preventice Solutions, a provider of mobile cardiac health solutions, for an upfront cash payment of $925 million and up to $300 million in potential milestone payments. Boston Scientific already holds a 22% stake.
Baring Private Equity Asia investor Baring Private Equity Asia partner Boston Scientific acquirer Lumenis target Preventice Solutions, Inc. target #Medical Devices news.bostonscientific.com news.bloomberglaw.com prnewswire.com

Suppliers

Acquired by

Loading…